Odyssey Therapeutics (ODTX) Research & Development (2023 - 2026)
Odyssey Therapeutics (ODTX) posted Research & Development of $42.12 million for Q3 2026, up 60.0% from $26.33 million a year earlier and up 16.3% from the prior quarter.
Odyssey Therapeutics (ODTX) Research & Development (2023 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Research & Development at Odyssey Therapeutics was $141.96 million, up 11.9% year-over-year; for FY2025, it came in at $126.62 million, up 12.5% from FY2024.
- Annual Research & Development has increased for three consecutive years, with a three-year compound annual growth rate of 7.6% (FY2022 to FY2025).
- In prior years, Odyssey Therapeutics' Research & Development was $112.58 million in FY2024 (+0.3%), $112.28 million in FY2023 (+10.3%) and $101.76 million in FY2022.
- The Q3 2026 figure stands as the highest quarterly Research & Development in data going back to Q4 2023.
- On a year-over-year basis, Research & Development increased in three of the last five quarters, with growth averaging 16.9%.
- According to Business Quant data, Research & Development for the three prior quarters was $36.23 million (Q2 2026), $32.32 million (Q1 2026) and $31.29 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Odyssey Therapeutics | 929.15 Mn | -64.53 Mn | - | 42.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 42.12 Mn |
| Jun 30, 2026 | 36.23 Mn |
| Mar 31, 2026 | 32.32 Mn |
| Dec 31, 2025 | 31.29 Mn |
| Sep 30, 2025 | 26.33 Mn |
| Jun 30, 2025 | 30.23 Mn |
| Mar 31, 2025 | 38.77 Mn |
| Dec 31, 2024 | 31.48 Mn |
| Dec 31, 2023 | 25.80 Mn |
Odyssey Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ODTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ODTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ODTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();